Posts

Multiple uses of tropical mosaic landscapes

Many landscapes in the tropics consist of a mosaic of different types of land us...

DBST: a lightweight block cipher based on dynamic S-box

Block ciphers, a branch of modern cryptography, are playing a more prominent rol...

Atypical infections in chronic sinusitis: thinking outs...

“[…] in many cases [of chronic sinusitis] only symptom control is achieved.” Cre...

Remote plant worlds

Oceanic islands provide useful models for ecology, biogeography and evolutionary...

Your neighborhood may increase risk of hospitalization ...

The range of COVID-19 symptoms varies—some feel a mild cold, others are hospital...

Mobile app enables students with special needs to self-...

COLUMBIA, Mo. — When Sara Estrapala started her career as a high school paraeduc...

BeiGene and DualityBio Announce Partnership for Solid T...

Sino-American biotech company BeiGene has announced its acquisition of China-bas...

FDA lifts remaining partial ban from Curis’ late-stage ...

The Food and Drug Administration (FDA) in the U.S. has completely lifted the par...

Takeda Pulls Application For Dengue Vaccine Qdenga

Travelers and medical professionals from the U.S. who are hoping for a different...

Opdivo by Bristol Myers Shows Positive Results in Phase...

According to the results of a late-stage clinical trial, Opdivo, an immunotherap...

Atrial fibrillation market set to decline at a CAGR of ...

Atrial fibrillation drugs' patent expiration is largely responsible for the pred...

HTA outcomes in the 5EU are growing at 27% with a deep ...

GlobalData has analysed HTA decisions made for branded medicines in 5EU from 201...

Roche eyes alternate mode of administration for Ocrevus...

The investigation combines Ocrevus’ subcutaneous formulation with Halozyme’s dru...

Tenpoint raises funds to develop cell therapies for vis...

Tenpoint Therapeutics has raised Series A funds of $70m for developing engineere...

FDA accepts BeiGene’s sNDA for follicular lymphoma therapy

The US FDA has accepted for review BeiGene’s sNDA for Brukinsa plus obinutuzumab...

ICR to enter AI-powered cancer drug discovery partnership

Scientists at the ICR, London are set to enter a partnership to merge capabiliti...